Complement-based Drug Development Summit Europe
In-Person Event
Mar 20 - 22, 2018
London, England, GB
OVERVIEW
Complement-based Drug Development Summit Europe is organized by Hanson Wade and will be held during Mar 20 - 22, 2018 at Hilton London Olympia, London, England, United Kingdom.
This conference brings together the leading drug developers to advance the next generation of complement therapeutics, to gain cutting-edge insight from the key complement researchers and aims to develop the foundation of scientific knowledge in this field.
With the first generation of complement therapeutics set to be approved in the next couple of years, this is the perfect time to look ahead to the second generation. Join the Complement based drug development Summit to understand how you can treat an impressive range of broader conditions with complement therapeutics, navigate the European regulatory landscape and examine EMA guidelines with the expectations to ensure that drugs gain market approval smoothly.
This conference is the first industry-dedicated meeting focused on optimizing clinical trial design, efficacy assessment, target identification and expansion beyond orphan diseases.
Across 3 content-packed days, the field's thought leaders from GSK, Novartis, Complement Pharma and many more will be sharing their insight and lessons learned, collectively enabling the community to:
• Analysing Points of Inhibition: Assess the most effective points of complement inhibition for the treatment of individual diseases and the selection of therapeutic approaches for inhibition.
• Optimise Clinical Trial Design: Fine-tune clinical trial design for expansion beyond orphan diseases, advancing patient stratification, targeting, dosing, endpoints and sample handling.
• Standardising Efficacy Assessment: Define the next steps toward achieving standardisation of robust, functional assays in order to accurately determine treatment efficacy.
• Advancing Safety Profiles: Ensure patient safety by enhancing the management of off-target effects and approaches for minimising infection risk.
• Navigating the Regulatory Landscape: Streamline the regulatory approval process by examining guidelines and expectations, ensuring that drugs reach the market smoothly.
Join the Complement-based Drug Development Summit Europe to build the scaffold upon which complement therapeutics can be expanded beyond the treatment of ultra-rare diseases.
Prices:
Gold: Conference and 2 Workshops: GBP 2997,
Silver: Conference and 1 Workshops: GBP 2598,
Bronze: Conference only: GBP 1999,
Workshop: GBP 599
Speakers: Anna Schubart (Novartis), Andrea Tenner (University of California), Michael Holers (University of Colorado), Paul Morgan (Cardiff University), Eva-Maria Nichols (GlaxoSmithKline), Michael Kirschfink (University of Heidelberg), Frank Baas (Complement Pharma), Ashley Frazer-Abel (Exsera Biolabs), Andrea Tenner (University of California), Anna Blom (Lund University), Anne Bruns (aHUS Foundation), Erik Hack (Prothix), Kiran Nistala (GlaxoSmithKline), Kai Höhlig (Aptarion Biotech AG), Richard Smith Director (King's College London), Tom Mollnes (University of Oslo)
This conference brings together the leading drug developers to advance the next generation of complement therapeutics, to gain cutting-edge insight from the key complement researchers and aims to develop the foundation of scientific knowledge in this field.
With the first generation of complement therapeutics set to be approved in the next couple of years, this is the perfect time to look ahead to the second generation. Join the Complement based drug development Summit to understand how you can treat an impressive range of broader conditions with complement therapeutics, navigate the European regulatory landscape and examine EMA guidelines with the expectations to ensure that drugs gain market approval smoothly.
This conference is the first industry-dedicated meeting focused on optimizing clinical trial design, efficacy assessment, target identification and expansion beyond orphan diseases.
Across 3 content-packed days, the field's thought leaders from GSK, Novartis, Complement Pharma and many more will be sharing their insight and lessons learned, collectively enabling the community to:
• Analysing Points of Inhibition: Assess the most effective points of complement inhibition for the treatment of individual diseases and the selection of therapeutic approaches for inhibition.
• Optimise Clinical Trial Design: Fine-tune clinical trial design for expansion beyond orphan diseases, advancing patient stratification, targeting, dosing, endpoints and sample handling.
• Standardising Efficacy Assessment: Define the next steps toward achieving standardisation of robust, functional assays in order to accurately determine treatment efficacy.
• Advancing Safety Profiles: Ensure patient safety by enhancing the management of off-target effects and approaches for minimising infection risk.
• Navigating the Regulatory Landscape: Streamline the regulatory approval process by examining guidelines and expectations, ensuring that drugs reach the market smoothly.
Join the Complement-based Drug Development Summit Europe to build the scaffold upon which complement therapeutics can be expanded beyond the treatment of ultra-rare diseases.
Prices:
Gold: Conference and 2 Workshops: GBP 2997,
Silver: Conference and 1 Workshops: GBP 2598,
Bronze: Conference only: GBP 1999,
Workshop: GBP 599
Speakers: Anna Schubart (Novartis), Andrea Tenner (University of California), Michael Holers (University of Colorado), Paul Morgan (Cardiff University), Eva-Maria Nichols (GlaxoSmithKline), Michael Kirschfink (University of Heidelberg), Frank Baas (Complement Pharma), Ashley Frazer-Abel (Exsera Biolabs), Andrea Tenner (University of California), Anna Blom (Lund University), Anne Bruns (aHUS Foundation), Erik Hack (Prothix), Kiran Nistala (GlaxoSmithKline), Kai Höhlig (Aptarion Biotech AG), Richard Smith Director (King's College London), Tom Mollnes (University of Oslo)
KEY DATES
20 Mar, 2018
Event Start Date
22 Mar, 2018
Event End Date
SUGGESTED HOTELS
CONFERENCE VENUE
Hilton London OlympiaQuick Links